Add this topic to your myFT Digest for news straight to your inbox
Often criticised for overcharging for drugs, will the speed at which the industry has responded to the pandemic change minds?
US Black Friday ecommerce sales set to increase 40 per cent on last year
Lack of clarity about trial results published this week has provoked a storm of criticism
The commitment is not just about national pride but also national interest
Midwest states have become pandemic hotbed after summer of flouting public health advice
Airlines and employers that ask for proof of coronavirus immunity will be acting in the public interest
Oxford university acknowledges error that forced trial to switch dosing regimens
Moncef Slaoui, the pharma industry veteran who joined US federal Covid programme, feels vindicated
Communist party newspaper tries to undermine belief virus jumped to humans within the country
Even vaccine-hesitant countries show high levels of uptake for inoculations, and Covid-19 will be no different
Proportionately more people north of border have been dying of coronavirus than in England
Millions travel for the holiday despite ‘dramatic’ spike in coronavirus cases and deaths
Officials say UK capital expected to be in tier two after lobbying of Number 10
Conspiracy theories about vaccines could affect how smoothly the world recovers from the coronavirus crisis
British moneymaker announces sevenfold increase in first-half adjusted operating profits
Analysts hail recent positive trial results as ‘game changer’ for the sector
University recognised the virus threat early and launched a full-scale research onslaught
Four nations agree relaxation of coronavirus restrictions for 5-day period
Travellers using exemption would not able to socialise during visits of up to three days
Telecoms companies asked to assess 47 locations to ensure they can open by next week to inoculate NHS workers
Technology has offered Boris Johnson an opportunity he must seize
International Edition
